Biomedical Advanced Research and Development Authority (BARDA)
District of Columbiaaspr.hhs.gov
Overview
BARDA is a U.S. government entity within the Department of Health and Human Services that provides funding and support for the development and procurement of medical countermeasures. It aims to protect against bioterrorism (including chemical, biological, radiological, and nuclear threats), pandemic influenza, and emerging infectious diseases by partnering with private industry to move products from early development into the Strategic National Stockpile.
Portfolio Companies
12
Website
aspr.hhs.govInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Locus Biosciences | Jan 2026 | Grant | Co-investor |
| LTS Lohmann Therapie-Systeme AG | Jan 2025 | Grant | Lead |
| CyanVac LLC | Jun 2024 | Grant | Lead |
| HDT Bio Corp. | Jan 2024 | Grant | Co-investor |
| VenatoRx Pharmaceuticals | Oct 2023 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
